TrialLeukemia2019

Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study.

Akihiro Takeshita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.